Insider Transactions in Q3 2025 at Bridge Bio Pharma, Inc. (BBIO)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 05
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-0.44%
|
$2,080,000
$52.97 P/Share
|
|
Sep 05
2025
|
Frank Mccormick Director |
SELL
Open market or private sale
|
Direct |
74,000
-47.05%
|
$3,922,000
$53.16 P/Share
|
|
Sep 05
2025
|
Frank Mccormick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
74,000
+32.0%
|
$814,000
$11.92 P/Share
|
|
Sep 04
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-0.65%
|
$2,040,000
$51.5 P/Share
|
|
Aug 21
2025
|
Thomas Trimarchi President and CFO |
SELL
Open market or private sale
|
Direct |
42,237
-9.12%
|
$2,069,613
$49.48 P/Share
|
|
Aug 20
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
26,156
-5.26%
|
$1,281,644
$49.03 P/Share
|
|
Aug 18
2025
|
Thomas Trimarchi President and CFO |
SELL
Open market or private sale
|
Direct |
17,353
-1.81%
|
$867,650
$50.54 P/Share
|
|
Aug 16
2025
|
Thomas Trimarchi President and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,317
-4.25%
|
$1,087,167
$51.32 P/Share
|
|
Aug 16
2025
|
Maricel Apuli Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,781
-3.37%
|
$243,831
$51.32 P/Share
|
|
Aug 16
2025
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,855
-11.65%
|
$1,675,605
$51.32 P/Share
|
|
Aug 16
2025
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
64,697
+18.66%
|
-
|
|
Aug 11
2025
|
Charles J Homcy |
SELL
Open market or private sale
|
Direct |
50,000
-5.17%
|
$2,400,000
$48.0 P/Share
|
|
Aug 08
2025
|
Charles J Homcy |
SELL
Open market or private sale
|
Direct |
250,000
-10.72%
|
$11,500,000
$46.25 P/Share
|
|
Aug 08
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-0.64%
|
$1,840,000
$46.3 P/Share
|
|
Aug 07
2025
|
Maricel Apuli Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.7%
|
$45,000
$45.44 P/Share
|
|
Aug 07
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-0.63%
|
$1,800,000
$45.37 P/Share
|
|
Aug 05
2025
|
Andrea Ellis |
SELL
Open market or private sale
|
Direct |
17,167
-48.01%
|
$841,183
$49.0 P/Share
|
|
Aug 05
2025
|
Andrea Ellis |
BUY
Exercise of conversion of derivative security
|
Direct |
17,167
+32.44%
|
$274,672
$16.75 P/Share
|
|
Jul 02
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-1.23%
|
$1,680,000
$42.73 P/Share
|
|
Jul 01
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-0.61%
|
$1,680,000
$42.7 P/Share
|